ResMed Wins Initial Decision in ITC Patent Infringement Action
SYDNEY and SAN DIEGO, Aug. 25, 2014 /PRNewswire/ -- An administrative law judge at the International Trade Commission (ITC) ruledFriday August 22 in a patent infringement case brought by ResMed (NYSE: RMD) against Chinese medical device manufacturer BMC Medical Co., Ltd., that each of nine BMC pr...
A New Beginning: ResMed's New Air Solutions Connected Care Platform for Treating Sleep-Disordered Breathing
SAN DIEGO, Aug. 11, 2014 /PRNewswire/ -- ResMed (NYSE: RMD) today announced Air Solutions, a new forward-thinking connected care solution for treating sleep-disordered breathing that can benefit all stakeholders in the care continuum. The ResMed Air Solutions platform has data-driven components t...
ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe
MUNICH, July 28, 2014 /PRNewswire/ -- ResMed (NYSE: RMD), an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and other chronic respiratory conditions, has won a permanent injunction in Germany against Taiwanese medical device manufacturer APEX Medical...
ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents
SAN DIEGO, July 21, 2014 /PRNewswire/ -- An International Trade Commission (ITC) ruling issued Friday held that, despite a redesign of its iCH CPAP device, Taiwanese device manufacturer APEX continues to infringe ResMed patents in its humidification. ResMed (NYSE: RMD) is the innovation leader an...
